# A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I

> **NCT06162338** · NA · RECRUITING · sponsor: **He Huang** · enrollment: 3 (estimated)

## Conditions studied

- Gaucher Disease Type I

## Interventions

- **BIOLOGICAL:** LY-M001 Injection

## Key facts

- **NCT ID:** NCT06162338
- **Lead sponsor:** He Huang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-15
- **Primary completion:** 2026-12-17
- **Final completion:** 2031-12-17
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162338, "A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06162338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*